Using Reinforcement Learning to Personalize Electronic Health Record Tools to Facilitate Deprescribing
REINFORCE-EHR
2 other identifiers
interventional
1,249
1 country
1
Brief Summary
The overall goal of the proposed research is to refine and adapt and perform efficacy testing of a novel reinforcement learning-based approach to personalizing EHR-based tools for PCPs on deprescribing of high-risk medications for older adults. The trial will be conducted at Atrius Health, an integrated delivery network in Massachusetts, and will intervene upon primary care providers. The investigators will conduct a cluster randomized trial using reinforcement learning to adapt electronic health record (EHR) tools for deprescribing high-risk medications versus usual care. 70 PCPs will be randomized (i.e., 35 each to the reinforcement learning intervention and usual care \[no EHR tool\] in each arm) to the trial and follow them for approximately 30 weeks. The primary outcome will be discontinuation or ordering a dose taper for the high-risk medications for eligible patients by included primary care providers, using EHR data at Atrius. The primary hypothesis is that the personalized intervention using reinforcement learning will improve deprescribing compared with usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedStudy Start
First participant enrolled
August 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2026
CompletedApril 2, 2026
November 1, 2025
8 months
October 24, 2024
March 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Discontinuation or taper for high-risk medication
Deprescribing will be assessed using routinely collected data from the EHR system for eligible patients flagged as in need of deprescribing. The deprescribing outcome will be a "reduction" in inappropriate prescribing, defined as either discontinuation of one the the medication classes of interest or ordering a dose taper.
Through trial completion, up to 7 months
Secondary Outcomes (1)
Discontinuation of high-risk medication
Through trial completion, up to 7 months
Study Arms (2)
Reinforcement learning intervention
EXPERIMENTALThe intervention is a reinforcement learning program that personalizes EHR-based tools for PCPs to promote deprescribing high-risk medications over follow-up. The reinforcement learning intervention selects a tool for each provider based on an algorithm from an inventory of EHR tools and chooses tools that are predicted to motivate action for the individual provider. The effectiveness of each tool will be assessed on a selected interval based on whether a deprescribing action is taken by PCPs for eligible patients. The algorithm is trained to maximize these actions over time.
Usual care
NO INTERVENTIONNo EHR-based tools provided beyond those used in regular clinical practice.
Interventions
The intervention is a reinforcement learning program that personalizes EHR-based tools for PCPs to promote deprescribing high-risk medications over follow-up. The reinforcement learning intervention selects a tool for each provider based on an algorithm from an inventory of EHR tools and chooses tools that are predicted to motivate action for the individual provider. The inventory of EHR tools from which the algorithm will choose include the following potential factors: open encounter, order entry, cold-state outreach, simplification, and risk framing.
Eligibility Criteria
You may qualify if:
- The trial will intervene upon primary care providers (including physicians and PCP-designated nurse practitioners and physician assistants) at Atrius Health.
- Patients of the PCPs will be included in the intervention and analysis if they are \>/=65 years of age and have been prescribed \>/= 90 pills of high-risk medications in the prior 180 days based on EHR data.
You may not qualify if:
- Not a primary care provider at Atrius Health
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute on Aging (NIA)collaborator
- Atrius Healthcollaborator
- Brigham and Women's Hospitallead
Study Sites (1)
Atrius Health
Boston, Massachusetts, 02215, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 24, 2024
First Posted
October 28, 2024
Study Start
August 11, 2025
Primary Completion
March 27, 2026
Study Completion
March 27, 2026
Last Updated
April 2, 2026
Record last verified: 2025-11